Premier Biotech Acquires Desert Tox

June 6, 2024

Premier Biotech, a toxicology testing provider backed by Align Capital Partners, has acquired Desert Tox, LLC, a SAMHSA‑certified laboratory that provides urine and oral fluid testing across HHS/DOT, employment, occupational health and government markets. The founders, Mike Grommes and Mike Gorman, will remain involved; the deal is Premier's first add-on since ACP's acquisition in November 2022 and expands Premier's national service offering and oral fluids capabilities.

Targets
Desert Tox, LLC
Sellers
Mike Grommes, Mike Gorman
Platforms
Premier Biotech
Location
Arizona, United States
Transaction Type
Addon

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.